This website uses cookies to enhance the user experience.
T

TIDEWAVE MEDICAL AS918 491 775

Research
Limited company
Hillevågsveien 101 4016 STAVANGER, Norge

TIDEWAVE MEDICAL AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
7 years
since Feb 7, 2017
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
375,664
1 share class
Total number of shareholders
39
18 companies, 21 persons

Financials

Total operating income 2023
1,412,148
NOK
Annual total result 2023
-9,649,118
NOK
Total equity 2023
1,723,108
NOK
Last update: Oct 14, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
9.76 %
directly

Board

NameRoleShares
Chairman-
Board Member
1.8 %
indirectly
Board Member-
AH
Board Member-
Board Member-

Others

NameRoleShares
P
PRICEWATERHOUSECOOPERS AS
Auditor-
R
RANDABERG REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
10.02 %
directly 0.27 %
indirectly 9.76 %
Managing Director/CEO
9.76 %
directly
-
9.76 %
directly
-
9.76 %
directly
-
4.64 %
indirectly
-
3.44 %
directly
-
3.19 %
directly
-
2.76 %
indirectly
-
2.28 %
indirectly
Board Member
1.8 %
indirectly
Last update: Jun 24, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
D
DSD INVESTERING AS
Ordinary shares
95,538
25.43 %
Ordinary shares
36,654
9.76 %
Ordinary shares
36,654
9.76 %
Ordinary shares
36,654
9.76 %
P
PROTONIC AS
Ordinary shares
36,654
9.76 %
B
BANTRY INVEST AS
Ordinary shares
17,439
4.64 %
T
T S HOLDING AS
Ordinary shares
15,253
4.06 %
Ordinary shares
12,923
3.44 %
Ordinary shares
12,000
3.19 %
T
TIDEWAVE MEDICAL AS
Ordinary shares
11,671
3.11 %
N
NAVINE INVEST AS
Ordinary shares
8,547
2.28 %
Ordinary shares
8,015
2.13 %
B
BEINEVEIEN AS
Ordinary shares
6,770
1.8 %
G
GS CONSULTING AS
Ordinary shares
5,563
1.48 %
R
RESULTATFORUM AS
Ordinary shares
4,271
1.14 %
S
SIFRE AS
Ordinary shares
3,832
1.02 %
A
ASPHEIMEN AS
Ordinary shares
3,800
1.01 %
D
DISRUPT SA
Ordinary shares
2,663
0.71 %
V
VINKEL INVEST AS
Ordinary shares
2,160
0.57 %
E
EK KONSULENTTJENESTER AS
Ordinary shares
2,065
0.55 %
Ordinary shares
1,906
0.51 %
Ordinary shares
1,700
0.45 %
Ordinary shares
1,700
0.45 %
Ordinary shares
1,248
0.33 %
Ordinary shares
1,138
0.3 %
Ordinary shares
1,000
0.27 %
Ordinary shares
1,000
0.27 %
Ordinary shares
1,000
0.27 %
Ordinary shares
953
0.25 %
H
HERMES GROUP AS
Ordinary shares
828
0.22 %
Ordinary shares
600
0.16 %
Ordinary shares
500
0.13 %
Ordinary shares
477
0.13 %
R
RØYS INVEST AS
Ordinary shares
461
0.12 %
E
EDERA AS
Ordinary shares
414
0.11 %
Ordinary shares
413
0.11 %
Ordinary shares
400
0.11 %
Ordinary shares
400
0.11 %
YB

Yu Bai

1980

Ordinary shares
400
0.11 %

Shares owned by the TIDEWAVE MEDICAL AS

NameShare classNumber of sharesShare
T
TIDEWAVE MEDICAL AS
Ordinary shares
11,671
3.11 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
1,412,148
4,780,859
6,197,879
Annual Total Result
-9,649,118
-8,790,884
-3,126,566
Total assets
5,623,191
10,072,282
20,121,694
Total liabilities
3,900,084
3,778,600
3,750,128
Total equity
1,723,108
6,293,682
16,371,566

P&L

Year202320222021
Total operating income
1,412,148
4,780,859
6,197,879
Total operating costs
10,921,292
13,558,591
9,326,593
Operating result
-9,509,145
-8,777,732
-3,128,714
Financial income/costs
-139,973
-13,152
2,149
Profit before tax
-9,649,118
-8,790,884
-3,126,566
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-9,649,118
-8,790,884
-3,126,566

Balance overview

Year202320222021
Total fixed assets
2,091,996
2,449,149
2,799,923
Total current assets
3,531,196
7,623,133
17,321,770
Total assets
5,623,191
10,072,282
20,121,694
Short term debt
3,900,084
1,378,600
1,350,128
Long term debt
0
2,400,000
2,400,000
Total liabilities
3,900,084
3,778,600
3,750,128
Contributed capital
28,815,402
23,736,858
23,736,858
Retained earnings
-27,092,294
-17,443,176
-7,365,292
Total equity
1,723,108
6,293,682
16,371,566
Total equity and liabilities
5,623,191
10,072,282
20,121,694

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology